Latest Period
Q1 2026
Security Snapshot
Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) Institutional Ownership
CUSIP: M40527109
13F Institutional Holders and Ownership History from Q2 2018 to Q1 2026
Institutions Reporting
26
Shares (Excl. Options)
7,871,783
Price
$1.11
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Ordinary shares, par value NIS 0.0000769 per share
- Symbol
- ENTX on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 7,871,783
- Total 13F value
- $8,677,875
- Portfolio coverage rank
- 0%
- Share change
- -1,471,094
- Value change
- -$1,722,017
- Number of holders
- 26
- Shares outstanding
- 45,504,462
- SEC-reported price per share
- $1.21
- Insider filing price
- $1.21
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- ENTX - Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share is tracked under CUSIP M40527109.
- 26 institutions reported positions in Q1 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 22 to 26 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $18,125,113 to $8,677,875.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 26 institutions filings for Q1 2026.
Security key
M40527109
Latest holder period
Q1 2026
13F holders
26
13D/G owners
2
CIK / CUSIP context first
Open Q1 2026 holders
ENTX full holder history
Entera Bio Ltd. SEC filings
Entera Bio Ltd. company facts
Entera Bio Ltd. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP M40527109:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
ENTX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| OPKO HEALTH, INC. | 8.1% | $8,660,281 | 3,685,226 | OPKO HEALTH, INC. | 16 Mar 2025 | |||
| Point72 Asset Management, L.P. | 2.6% | -60% | $2,271,583 | -$2,915,412 | 1,183,116 | -56% | Point72 Asset Management, L.P. | 30 Sep 2025 |
As of 31 Mar 2026, 26 institutional investors reported holding 7,871,783 shares of Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX). This represents 17% of the company’s total 45,504,462 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
17%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Knoll Capital Management, LLC | 13% | 5,881,879 | 0% | 3.6% | $6,470,066 |
| RENAISSANCE TECHNOLOGIES LLC | 1% | 473,442 | +338% | 0% | $525,521 |
| Parkman Healthcare Partners LLC | 0.63% | 288,670 | +4.9% | 0.03% | $320,424 |
| CITADEL ADVISORS LLC | 0.54% | 245,577 | +510% | 0% | $272,590 |
| Seven Fleet Capital Management LP | 0.45% | 205,542 | +52% | 0.07% | $228,152 |
| MARSHALL WACE, LLP | 0.43% | 195,780 | -69% | 0% | $217,316 |
| NORTHERN TRUST CORP | 0.32% | 146,854 | -1.2% | 0% | $163,008 |
| XTX Topco Ltd | 0.29% | 131,622 | 0% | $146,100 | |
| Schonfeld Strategic Advisors LLC | 0.12% | 55,223 | -91% | 0% | $61,296 |
| SIGNATURE ESTATE & INVESTMENT ADVISORS LLC | 0.1% | 47,328 | 0% | 0% | $52,534 |
| HighTower Advisors, LLC | 0.08% | 36,830 | -15% | 0% | $40,881 |
| JANE STREET GROUP, LLC | 0.07% | 32,915 | -56% | 0% | $36,536 |
| DIADEMA PARTNERS LP | 0.05% | 23,260 | 0.01% | $25,819 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.05% | 21,136 | 0% | 0% | $23,460 |
| Gem Investment Advisors, LLC | 0.04% | 19,135 | 0% | 0.02% | $21,240 |
| HRT FINANCIAL LP | 0.03% | 15,492 | 0% | $17,000 | |
| Point72 Asset Management, L.P. | 0.03% | 12,382 | -99% | 0% | $13,744 |
| BANK OF AMERICA CORP /DE/ | 0.03% | 12,000 | -20% | 0% | $13,320 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.02% | 10,000 | 0% | 0% | $11,100 |
| JPMORGAN CHASE & CO | 0.02% | 7,150 | 0% | $7,150 | |
| Persistent Asset Partners Ltd | 0.01% | 5,881 | 0% | $6,528 | |
| UBS Group AG | 0.01% | 3,212 | +18794% | 0% | $3,565 |
| MORGAN STANLEY | 0% | 400 | 0% | $444 | |
| GROUP ONE TRADING LLC | 0% | 51 | 0% | 0% | $57 |
| Caitong International Asset Management Co., Ltd | 0% | 20 | 0% | $22 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
32
Latest
Q1 2026
Rows shown
1-25 of 32
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 7,871,783 | $8,677,875 | -$1,722,017 | $1.11 | 26 |
| 2025 Q4 | 9,342,877 | $18,125,113 | +$502 | $1.94 | 22 |
| 2025 Q3 | 9,194,576 | $17,653,167 | -$1,951,360 | $1.92 | 21 |
| 2025 Q2 | 10,211,002 | $19,401,301 | +$12,863 | $1.90 | 19 |
| 2025 Q1 | 10,222,258 | $17,377,838 | +$4,637,662 | $1.70 | 18 |
| 2024 Q4 | 7,494,222 | $15,902,006 | +$4,661,706 | $2.12 | 14 |
| 2024 Q3 | 5,323,228 | $10,112,228 | +$57,454 | $1.90 | 17 |
| 2024 Q2 | 5,292,989 | $9,745,202 | +$1,916,835 | $1.84 | 14 |
| 2024 Q1 | 4,259,308 | $7,113,387 | +$404,057 | $1.67 | 14 |
| 2023 Q4 | 4,062,589 | $2,437,015 | +$887,868 | $0.60 | 9 |
| 2023 Q3 | 2,579,003 | $1,870,234 | +$4,206 | $0.72 | 11 |
| 2023 Q2 | 2,569,162 | $2,166,115 | -$314,934 | $0.84 | 10 |
| 2023 Q1 | 2,830,846 | $3,283,550 | -$215,433 | $1.16 | 8 |
| 2022 Q4 | 566,752 | $413,272 | -$1,176,817 | $0.73 | 10 |
| 2022 Q3 | 4,663,496 | $4,850,000 | -$254,655 | $1.04 | 8 |
| 2022 Q2 | 4,916,394 | $6,538,000 | -$45,964 | $1.33 | 9 |
| 2022 Q1 | 4,949,328 | $14,203,000 | -$2,021,499 | $2.86 | 10 |
| 2021 Q4 | 5,655,346 | $15,920,000 | -$38,159 | $2.82 | 10 |
| 2021 Q3 | 5,665,990 | $26,717,000 | +$2,489,496 | $4.71 | 13 |
| 2021 Q2 | 5,111,468 | $30,566,000 | +$18,924,636 | $5.98 | 14 |
| 2021 Q1 | 1,986,053 | $7,567,000 | +$563,572 | $3.81 | 7 |
| 2020 Q4 | 1,857,733 | $2,008,000 | -$82,677 | $1.09 | 5 |
| 2020 Q3 | 1,905,237 | $2,363,000 | -$160,746 | $1.24 | 5 |
| 2020 Q2 | 1,950,079 | $3,422,000 | -$82,244 | $1.83 | 5 |
| 2020 Q1 | 1,990,244 | $3,781,000 | +$137,000 | $1.99 | 3 |